Published Year: 2018
Global Injectable Drug Delivery Market : Focus on Devices, Competitive Landscape and Country - Analy
The global injectable drug delivery market was estimated at $16.73 billion in 2016 and is...
Market Research Report
A quick peek into the report
Table of Contents
Product Definition
2.1 Scope of Study
2.2 Inclusion and Exclusion Criteria
2.3 Key Questions Answered in the Report
3.1 Data Collection and Analysis
3.2 Data Sources
3.2.1 Primary Data Sources
3.2.2 Secondary Data Sources
3.3 Data Triangulation
3.4 Market Estimation
3.5 Forecast Period Selection Criteria
3.6 Assumptions and Limitations
4.1 Technology Landscape
4.1.1 Key Trends
4.1.1.1 Short-Term Potential (2-4 Years)
4.1.1.2 Mid-Term Potential (5-10 Years)
4.1.1.3 Long-Term Impact (8-12 Years)
4.2 Supply Chain Analysis
4.3 Funding Scenario
4.4 Regulatory Framework and Government Initiatives
4.4.1 Regulations in North America
4.4.1.1 U.S.
4.4.1.2 Canada
4.4.2 Regulations in Europe
4.4.3 Regulations in Asia-Pacific
4.4.3.1 Japan
4.4.3.2 China
4.5 Patent Analysis
4.5.1 Patent Filing Trend (by Country)
4.5.2 Patent Filing Trend (by Year)
5.1 Impact on Dermatology Practices
5.2 Impact on the Adoption of Advanced Dermatology Drug Delivery Devices
5.3 Impact on Market Size
5.4 Impact of COVID-19 on Global Advanced Dermatology Drug Delivery Devices Market
5.4.1 Short-Term Impact (2-4 Years)
5.4.2 Mid-Term Impact (5-10 Years)
5.4.3 Long-Term Impact (8-12 Years)
5.5 Entry Barriers and Opportunities
6.1 Market Share Analysis
6.2 Key Strategies and Developments
6.2.1 Funding Activities
6.2.2 Mergers and Acquisitions (M&A)
6.2.3 Partnerships, Alliances, and Business Expansions
6.2.4 Regulatory and Legal Activities
6.2.5 New Offerings
6.3 Business Model Analysis
6.4 Pricing Analysis
7.1 Assumptions and Limitations
7.2 Key Findings and Opportunity Assessment
7.3 Global Advanced Dermatology Drug Delivery Devices Market Size and Forecast
7.3.1 Realistic Growth Scenario
7.3.2 Pessimistic/Conservative Growth Scenario
7.3.3 Optimistic Growth Scenario
7.4 Market Dynamics
7.4.1 Impact Analysis
7.4.2 Market Growth Promoting Factors
7.4.2.1 Global Preference for Connected Devices
7.4.2.2 Increasing Number of Business Synergies with Pharmaceutical Companies
7.4.2.3 Novel Technologies in Drug Delivery
7.4.2.4 Growing Focus on Prescription Adherence
7.4.3 Market Growth Restraining Factors
7.4.3.1 Stringent Regulations and Concerns Around Data Privacy
7.4.3.2 Lack of Awareness Among a Large Section of the Population in Emerging Countries
7.4.4 Market Growth Opportunities
7.4.4.1 Development of a Customized Apps Marketplace for Pharma Companies
7.4.4.2 Leveraging Synergies to Expand into Emerging Markets
7.4.4.3 Developing Low-Cost Devices to Improve Sales in Price-Sensitive Markets
8.1 Opportunity Assessment
8.2 Growth Share Matrix
8.3 Hardware
8.3.1 Injectors
8.3.1.1 Key Players Competitive Benchmarking
8.3.1.2 Market Dynamics
8.3.1.3 Key Product Specifications
8.3.1.4 Unit Volume Sold
8.3.1.4.1 Key Players
8.3.1.4.2 End Market (OTC and Pharma)
8.3.1.5 Market Size and Forecast
8.3.1.5.1 Disposable Injectors
8.3.1.5.2 Reusable Injectors
8.3.1.5.3 Wearable Injectors
8.3.2 Patches
8.3.2.1 Key Players Competitive Benchmarking
8.3.2.2 Market Dynamics
8.3.2.3 Key Product Specifications
8.3.2.4 Unit Volume Sold
8.3.2.4.1 Key Players
8.3.2.4.2 End Market (OTC and Pharma)
8.3.2.5 Market Size and Forecast
8.3.2.5.1 Microneedle Patches (MNPs)
8.3.2.5.1.1 Solid Removable Microneedles
8.3.2.5.1.2 Coated Microneedles
8.3.2.5.1.3 Dissolving Microneedles
8.3.2.5.1.4 Hollow Microneedles
8.3.2.5.1.5 Hydrogel Forming Microneedles
8.3.2.5.2 Needle-Less Patches
8.3.3 Airless Dispensers and Bottles
8.3.3.1 Key Players Competitive Benchmarking
8.3.3.2 Market Dynamics
8.3.3.3 Key Product Specifications
8.3.3.4 Unit Volume Sold
8.3.3.4.1 Key Players
8.3.3.4.2 End Market (OTC and Pharma)
8.3.3.5 Market Size and Forecast
8.3.4 Dermal Pumps
8.3.4.1 Key Players Competitive Benchmarking
8.3.4.2 Market Dynamics
8.3.4.3 Key Product Specifications
8.3.4.4 Unit Volume Sold
8.3.4.4.1 Key Players
8.3.4.4.2 End Market (OTC and Pharma)
8.3.4.5 Market Size and Forecast
8.3.5 Valves
8.3.5.1 Key Players Competitive Benchmarking
8.3.5.2 Market Dynamics
8.3.5.3 Key Product Specifications
8.3.5.4 Unit Volume Sold
8.3.5.4.1 Key Players
8.3.5.4.2 End Market (OTC and Pharma)
8.3.5.5 Market Size and Forecast
8.3.6 Other Devices
8.3.6.1 Key Players Competitive Benchmarking
8.3.6.2 Market Dynamics
8.3.6.3 Key Product Specifications
8.3.6.4 Unit Volume Sold
8.3.6.4.1 Key Players
8.3.6.4.2 End Market (OTC and Pharma)
8.3.6.5 Market Size and Forecast
8.3.7 Packaging Products
8.3.7.1 Market Dynamics
8.3.7.2 Market Size and Forecast
8.4 Software and Apps
9.1 Opportunity Assessment
9.2 B2B Sales Channel
9.3 B2C Sales Channel
10.1 Opportunity Assessment
10.2 Hospitals
10.3 Dermatology Practices
10.4 Home Use
11.1 Overview
11.2 North America Advanced Dermatology Drug Delivery Devices Market
11.2.1 Key Findings and Opportunity Assessment
11.2.2 Market Dynamics Impact Analysis
11.2.3 Market Size and Forecast
11.2.4 North America Advanced Dermatology Drug Delivery Devices Market (by Product Type)
11.2.5 North America Advanced Dermatology Drug Delivery Devices Market (by End User)
11.2.6 North America Advanced Dermatology Drug Delivery Devices Market (by Country)
11.2.6.1 U.S.
11.2.6.2 Canada
11.3 Europe Advanced Dermatology Drug Delivery Devices Market
11.3.1 Key Findings and Opportunity Assessment
11.3.2 Market Dynamics: Impact Analysis
11.3.3 Market Size and Forecast
11.3.4 Europe Advanced Dermatology Drug Delivery Devices Market (by Product Type)
11.3.5 Europe Advanced Dermatology Drug Delivery Devices Market (by End User)
11.3.6 Europe Advanced Dermatology Drug Delivery Devices Market (by Country)
11.3.6.1 Germany
11.3.6.2 U.K.
11.3.6.3 France
11.3.6.4 Italy
11.3.6.5 Spain
11.3.6.6 Nordic Countries
11.3.6.7 Rest-of-Europe
11.4 Asia-Pacific Advanced Dermatology Drug Delivery Devices Market
11.4.1 Key Findings and Opportunity Assessment
11.4.2 Market Dynamics: Impact Analysis
11.4.3 Market Size and Forecast
11.4.4 Asia-Pacific Advanced Dermatology Drug Delivery Devices Market (by Product Type)
11.4.5 Asia-Pacific Advanced Dermatology Drug Delivery Devices Market (by End User)
11.4.6 Asia-Pacific Advanced Dermatology Drug Delivery Devices Market (by Country)
11.4.6.1 Japan
11.4.6.2 China
11.4.6.3 South Korea
11.4.6.4 Australia and New Zealand
11.4.6.5 India
11.4.6.6 Rest-of-Asia-Pacific
11.5 Latin America Advanced Dermatology Drug Delivery Devices Market
11.5.1 Key Findings and Opportunity Assessment
11.5.2 Market Dynamics Impact Analysis
11.5.3 Market Size and Forecast
11.5.4 Latin America Advanced Dermatology Drug Delivery Devices Market (by Product Type)
11.5.5 Latin America Advanced Dermatology Drug Delivery Devices Market (by End User)
11.5.6 Latin America Advanced Dermatology Drug Delivery Devices Market (by Country)
11.5.6.1 Brazil
11.5.6.2 Mexico
11.5.6.3 Argentina
11.5.6.4 Rest-of-Latin America
11.6 Rest-of-the-World Advanced Dermatology Drug Delivery Devices Market
11.6.1 Key Findings and Opportunity Assessment
11.6.2 Market Dynamics: Impact Analysis
11.6.3 Market Size and Forecast
11.6.4 Rest-of-the-World Advanced Dermatology Drug Delivery Devices Market (by Product Type)
11.6.5 Rest-of-the-World Advanced Dermatology Drug Delivery Devices Market (by End User)
12.1 AptarGroup, Inc.
12.1.1 Company Overview
12.1.2 Role of AptarGroup, Inc. in the Global Advanced Dermatology Drug Delivery Devices Market
12.1.3 Product Portfolio
12.1.3.1 Volume of Bottles Sold
12.1.3.1.1 Less than 50 ml
12.1.3.1.2 50ml-100ml
12.1.3.1.3 100ml-150ml
12.1.3.1.4 More than 150ml
12.1.4 Financials
12.1.5 Research and Development (R&D) Insights
12.1.6 Recent Developments
12.1.7 SWOT Analysis
12.2 Becton, Dickinson and Company
12.2.1 Company Overview
12.2.2 Role of Becton, Dickinson and Company in the Global Advanced Dermatology Drug Delivery Devices Market
12.2.3 Financials
12.2.4 Research and Development (R&D) Insights
12.2.5 SWOT Analysis
12.3 Bespak
12.3.1 Company Overview
12.3.2 Role of Bespak in the Global Advanced Dermatology Drug Delivery Devices Market
12.3.3 Recent Developments
12.3.4 SWOT Analysis
12.4 Credence MedSystems, Inc.
12.4.1 Company Overview
12.4.2 Role of Credence MedSystems, Inc. in the Global Advanced Dermatology Drug Delivery Devices Market
12.4.3 Recent Developments
12.4.4 SWOT Analysis
12.5 E3D Elcam Drug Delivery Devices
12.5.1 Company Overview
12.5.2 Role of E3D Elcam Drug Delivery Devices in the Global Advanced Dermatology Drug Delivery Devices Market
12.5.3 Recent Developments
12.5.4 SWOT Analysis
12.6 Kindeva Drug Delivery L.P.
12.6.1 Company Overview
12.6.2 Role of Kindeva Drug Delivery L.P. in the Global Advanced Dermatology Drug Delivery Devices Market
12.6.3 SWOT Analysis
12.7 Latch Medical
12.7.1 Company Overview
12.7.2 Role of Latch Medical in the Global Advanced Dermatology Drug Delivery Devices Market
12.7.3 Recent Developments
12.7.4 SWOT Analysis
12.8 LTS Lohmann Therapie-Systeme AG
12.8.1 Company Overview
12.8.2 Role of LTS Lohmann Therapie-Systeme AG in the Global Advanced Dermatology Drug Delivery Devices Market
12.8.3 Recent Developments
12.8.4 SWOT Analysis
12.9 Medicsensors S.L
12.9.1 Company Overview
12.9.2 Role of Medicsensors S.L in the Global Advanced Dermatology Drug Delivery Devices Market
12.9.3 SWOT Analysis
12.10 Midas Pharma GmbH
12.10.1 Company Overview
12.10.2 Role of Midas Pharma GmbH in the Global Advanced Dermatology Drug Delivery Devices Market
12.10.3 Recent Developments
12.10.4 SWOT Analysis
12.11 Nemera
12.11.1 Company Overview
12.11.2 Role of Nemera in the Global Advanced Dermatology Drug Delivery Devices Market
12.11.3 Recent Developments
12.11.4 SWOT Analysis
12.12 Owen Mumford
12.12.1 Company Overview
12.12.2 Role of Owen Mumford in the Global Advanced Dermatology Drug Delivery Devices Market
12.12.3 Recent Developments
12.12.4 SWOT Analysis
12.13 Portal Instruments, Inc.
12.13.1 Company Overview
12.13.2 Role of Portal Instruments, Inc. in the Global Advanced Dermatology Drug Delivery Devices Market
12.13.3 Recent Developments
12.13.4 SWOT Analysis
12.14 Vaxxas Inc.
12.14.1 Company Overview
12.14.2 Role of Vaxxas Inc. in the Global Advanced Dermatology Drug Delivery Devices Market
12.14.3 Recent Developments
12.14.4 SWOT Analysis
12.15 West Pharmaceutical Services, Inc.
12.15.1 Company Overview
12.15.2 Role of West Pharmaceutical Services, Inc. in the Global Advanced Dermatology Drug Delivery Devices Market
12.15.3 Financials
12.15.4 Research and Development (R&D) Insights
12.15.5 SWOT Analysis
Table 1: Key Barriers and Possible Solutions to Entering the Global Advanced Dermatology Drug Delivery Devices Market
Table 2: Global Advanced Dermatology Drug Delivery Devices Market Quarterly Key Developments Analysis, January 2017-June 2021
Table 3: Global Advanced Dermatology Drug Delivery Devices Market COVID-19 Recovery Scenario Impact
Table 4.1: Global Advanced Dermatology Drug Delivery Devices Market Technology Landscape
Table 4.2: Global Advanced Dermatology Drug Delivery Devices Market Funding, January 2017-January 2021
Table 4.3: European Commission Medical Device Directives
Table 5.1: Key Barriers and Possible Solutions in Entering into the Global Advanced Dermatology Drug Delivery Devices Market
Table 6.1: Global Advanced Dermatology Drug Delivery Devices Market Business Models
Table 6.2: Global Advanced Dermatology Drug Delivery Devices Market Pricing Analysis (by Product Type)
Table 7.1: Advanced Dermatology Drug Delivery Devices, Key Technologies
Table 8.1: Market Dynamics (Injectors)
Table 8.2: Key Product Specifications (Injectors)
Table 8.3: Unit Volume Sold (Injectors) – Key Players
Table 8.4: Market Dynamics (Patches)
Table 8.5: Key Product Specifications (Patches)
Table 8.6: Unit Volume Sold (Patches) – Key Players
Table 8.7: Market Dynamics (Airless Dispensers and Bottles)
Table 8.8: Key Product Specifications (Airless Dispensers and Bottles)
Table 8.9: Unit Volume Sold (Airless Dispensers and Bottles) – Key Players
Table 8.10: Market Dynamics (Dermal Pumps)
Table 8.11: Key Product Specifications (Dermal Pumps)
Table 8.12: Unit Volume Sold (Dermal Pumps) – Key Players
Table 8.13: Market Dynamics (Valves)
Table 8.14: Key Product Specifications (Valves)
Table 8.15: Unit Volume Sold (Valves) – Key Players
Table 8.16: Market Dynamics (Other Devices)
Table 8.17: Key Product Specifications (Other Devices)
Table 8.18: Unit Volume Sold (Other Devices) – Key Players
Table 8.19: Market Dynamics (Packaging Products)
Table 11.1: North America Advanced Dermatology Drug Delivery Devices Market Dynamics Impact Analysis
Table 11.2: Europe Advanced Dermatology Drug Delivery Devices Market Dynamics Impact Analysis
Table 11.3: Asia-Pacific Advanced Dermatology Drug Delivery Devices Market Dynamics Impact Analysis
Table 11.4: Latin America Advanced Dermatology Drug Delivery Devices Market Dynamics Impact Analysis
Table 11.5: Rest-of-the-World Advanced Dermatology Drug Delivery Devices Market Dynamics Impact Analysis
Figure 1: Global Advanced Dermatology Drug Delivery Devices Market Dynamics Impact Analysis
Figure 2: Potential COVID-19 Recovery Scenarios of Global Advanced Dermatology Drug Delivery Devices Market
Figure 2.1: Global Advanced Dermatology Drug Delivery Devices Market Segmentation
Figure 3.1: Global Advanced Dermatology Drug Delivery Devices Market, Research Methodology
Figure 3.2: Primary Research
Figure 3.3: Secondary Research
Figure 3.4: Data Triangulation
Figure 3.5: Global Advanced Dermatology Drug Delivery Devices Market Research Process
Figure 3.6: Assumptions and Limitations
Figure 4.1: Global Advanced Dermatology Drug Delivery Devices Market: Key Trends
Figure 4.2: Global Advanced Dermatology Drug Delivery Devices Market Key Trends, Short-Term Impact Analysis, 2023-2025
Figure 4.3: Global Advanced Dermatology Drug Delivery Devices Market, Key Trends, Mid-Term Impact Analysis, 2026-2031
Figure 4.4: Global Advanced Dermatology Drug Delivery Devices Market Key Trends, Long-Term Impact Analysis, 2029-2033
Figure 4.5: Global Advanced Dermatology Drug Delivery Device Supply Chain
Figure 4.6: Global Advanced Dermatology Drug Delivery Devices Market Funding Analysis, $Million, January 2017-January 2021
Figure 4.7: Global Advanced Dermatology Drug Delivery Devices Market, Patent Analysis (by Country), January 2018-June 2021
Figure 4.8: Global Advanced Dermatology Drug Delivery Devices Market, Patent Analysis (by Year), 2018-2021
Figure 5.1: Key Impact of COVID-19 on Global Advanced Dermatology Drug Delivery Devices Market
Figure 5.2: COVID-19 Impact on the Supply Chain of Global Advanced Dermatology Drug Delivery Market
Figure 5.3: COVID-19 Impact Analysis on Global Advanced Dermatology Drug Delivery Devices Adoption
Figure 6.1: Global Advanced Dermatology Drug Delivery Market, Company Revenue Share Analysis, $Million, 2020
Figure 6.2: Share of Key Developments and Strategies in the Global Advanced Dermatology Drug Delivery Devices Market (by Category), January 2017- June 2021
Figure 6.3: Global Advanced Dermatology Drug Delivery Devices Market Key Developments, January 2017-June 2021
Figure 6.4: Global Advanced Dermatology Drug Delivery Devices Market Funding Activities (by Company), January 2017-June 2021
Figure 6.5: Global Advanced Dermatology Drug Delivery Devices Market Mergers and Acquisitions (by Company), January 2017-June 2021
Figure 6.6: Global Advanced Dermatology Drug Delivery Devices Market Partnerships, Alliances, and Business Expansions (by Company), January 2017-June 2021
Figure 6.7: Global Advanced Dermatology Drug Delivery Devices Market Regulatory and Legal Activities (by Company), January 2017-June 2021
Figure 6.8: Global Advanced Dermatology Drug Delivery Devices Market New Offerings (by Company), January 2017-June 2021
Figure 7.1: Global Advanced Dermatology Drug Delivery Devices Market Incremental Opportunity, $Million, 2020-2030
Figure 7.2: Global Advanced Dermatology Drug Delivery Devices Market, Potential Forecast Scenarios
Figure 7.3: Global Advanced Dermatology Drug Delivery Devices Market Size and Growth Potential (Realistic Scenario), $Million, 2019-2030
Figure 7.4: Global Advanced Dermatology Drug Delivery Devices Market Size and Growth Potential (Pessimistic Scenario), $Million, 2019-2030
Figure 7.5: Global Advanced Dermatology Drug Delivery Devices Market Size and Growth Potential (Optimistic Scenario), $Million, 2019-2030
Figure 7.6: Global Advanced Dermatology Drug Delivery Devices Market Dynamics Impact Analysis
Figure 7.7: Global Advanced Dermatology Drug Delivery Devices Market, Connected Ecosystem
Figure 7.8: Global Advanced Dermatology Drug Delivery Devices Market, Medication Adherence Growth Benefits
Figure 8.1: Global Advanced Dermatology Drug Delivery Devices Market (by Product Type)
Figure 8.2: Global Advanced Dermatology Drug Delivery Devices Market Growth Share Matrix (by Product Type), 2020-2030
Figure 8.3: Global Advanced Dermatology Drug Delivery Devices Market (Hardware), $Million, 2019-2030
Figure 8.4: Global Advanced Dermatology Drug Delivery Devices Market Key Players Competitive Benchmarking (Injectors)
Figure 8.5: Injectors Market Volume Analysis, Million Unit, 2019-2030
Figure 8.6: Injectors Market Volume Analysis (by End Market), Million Unit, 2019-2030
Figure 8.7: Global Advanced Dermatology Drug Delivery Devices Market (Injectors), $Million, 2019-2030
Figure 8.8: Global Advanced Dermatology Drug Delivery Devices Market (Disposable Injectors), $Million, 2019-2030
Figure 8.9: Global Advanced Dermatology Drug Delivery Devices Market (Reusable Injectors), $Million, 2019-2030
Figure 8.10: Global Advanced Dermatology Drug Delivery Devices Market (Wearable Injectors), $Million, 2019-2030
Figure 8.11: Global Advanced Dermatology Drug Delivery Devices Market Key Players Competitive Benchmarking (Patches)
Figure 8.12: Patches Market Volume Analysis, Million Unit, 2019-2030
Figure 8.13: Patches Market Volume Analysis (by End Market), Million Unit, 2020
Figure 8.14: Global Advanced Dermatology Drug Delivery Devices Market (Patches), $Million, 2019-2030
Figure 8.15: Global Advanced Dermatology Drug Delivery Devices Market (MicroneedlePatches), $Million, 2019-2030
Figure 8.16: Global Advanced Dermatology Drug Delivery Devices Market (Solid Removable Microneedles), $Million, 2019-2030
Figure 8.17: Global Advanced Dermatology Drug Delivery Devices Market (Coated Microneedles), $Million, 2019-2030
Figure 8.18: Global Advanced Dermatology Drug Delivery Devices Market (Dissolving Microneedles), $Million, 2019-2030
Figure 8.19: Global Advanced Dermatology Drug Delivery Devices Market (Hollow Microneedles), $Million, 2019-2030
Figure 8.20: Global Advanced Dermatology Drug Delivery Devices Market (Hydrogel Forming Microneedles), $Million, 2019-2030
Figure 8.21: Global Advanced Dermatology Drug Delivery Devices Market (Needle-Less Patches), $Million, 2019-2030
Figure 8.22: Global Advanced Dermatology Drug Delivery Devices Market Key Players Competitive Benchmarking (Airless Dispensers and Bottles)
Figure 8.23: Airless Dispensers and Bottles Market Volume Analysis, Million Unit, 2019-2030
Figure 8.24: Airless Dispensers and Bottles Market Volume Analysis (by End Market), Million Unit, 2020
Figure 8.25: Global Advanced Dermatology Drug Delivery Devices Market (Airless Dispensers and Bottles), $Million, 2019-2030
Figure 8.26: Global Advanced Dermatology Drug Delivery Devices Market Key Players Competitive Benchmarking (Dermal Pumps)
Figure 8.27: Dermal Pumps Market Volume Analysis, Million Unit, 2019-2030
Figure 8.28: Dermal Pumps Market Volume Analysis (by End Market), Million Unit, 2020
Figure 8.29: Global Advanced Dermatology Drug Delivery Devices Market (Dermal Pumps), $Million, 2019-2030
Figure 8.30: Global Advanced Dermatology Drug Delivery Devices Market Key Players Competitive Benchmarking (Valves)
Figure 8.31: Valves Market Volume Analysis, Million Unit, 2019-2030
Figure 8.32: Valves Market Volume Analysis (by End Market), Million Unit, 2020
Figure 8.33: Global Advanced Dermatology Drug Delivery Devices Market (Valves), $Million, 2019-2030
Figure 8.34: Global Advanced Dermatology Drug Delivery Devices Market Key Players Competitive Benchmarking (Other Devices)
Figure 8.35: Other Devices Market Volume Analysis, Million Unit, 2019-2030
Figure 8.36: Other Devices Market Volume Analysis (by End Market), Million Unit, 2020
Figure 8.37: Global Advanced Dermatology Drug Delivery Devices Market (Other Devices), $Million, 2019-2030
Figure 8.38: Global Advanced Dermatology Drug Delivery Devices Market (Packaging Products), $Million, 2019-2030
Figure 8.39: Global Advanced Dermatology Drug Delivery Devices Market (Software and Apps), $Million, 2019-2030
Figure 9.1: Global Advanced Dermatology Drug Delivery Devices Market (by Sales Channel)
Figure 9.2: Global Advanced Dermatology Drug Delivery Devices Market Incremental Opportunity (by Sales Channel), $Million, 2020-2030
Figure 9.3: Global Advanced Dermatology Drug Delivery Devices Market (B2B Sales Channel), $Million, 2019-2030
Figure 9.4: Global Advanced Dermatology Drug Delivery Devices Market (B2C Sales Channel), $Million, 2019-2030
Figure 10.1: Global Advanced Dermatology Drug Delivery Devices Market (by End User)
Figure 10.2: Global Advanced Dermatology Drug Delivery Devices Market Incremental Opportunity (by End User), $Million, 2020-2030
Figure 10.3: Global Advanced Dermatology Drug Delivery Devices Market (Hospitals), $Million, 2019-2030
Figure 10.4: Global Advanced Dermatology Drug Delivery Devices Market (Dermatology Practices), $Million, 2019-2030
Figure 10.5: Global Advanced Dermatology Drug Delivery Devices Market (Home Use), $Million, 2019-2030
Figure 11.1: Global Advanced Dermatology Drug Delivery Devices Market Share (by Region), 2020-2030
Figure 11.2: North America Advanced Dermatology Market Incremental Revenue Opportunity (by Country), $Million, 2020-2030
Figure 11.3: North America Advanced Dermatology Drug Delivery Devices Market, $Million, 2019-2030
Figure 11.4: North America Advanced Dermatology Drug Delivery Devices Market (by Product Type), $Million, 2019-2030
Figure 11.5: North America Advanced Dermatology Drug Delivery Devices Market (by End User), $Million, 2019-2030
Figure 11.6: U.S. Advanced Dermatology Drug Delivery Devices Market, $Million, 2019-2030
Figure 11.7: Canada Advanced Dermatology Drug Delivery Devices Market, $Million, 2019-2030
Figure 11.8: Europe Advanced Dermatology Drug Delivery Devices Market Incremental Opportunity (by Country), $Million, 2020-2030
Figure 11.9: Europe Advanced Dermatology Drug Delivery Devices Market, $Million, 2019-2030
Figure 11.10: Europe Advanced Dermatology Drug Delivery Devices Market (by Product Type), $Million, 2019-2030
Figure 11.11: Europe Advanced Dermatology Drug Delivery Devices Market (by End User), $Million, 2019-2030
Figure 11.12: Germany Advanced Dermatology Drug Delivery Devices Market, $Million, 2019-2030
Figure 11.13: U.K. Advanced Dermatology Drug Delivery Devices Market, $Million, 2019-2030
Figure 11.14: France Advanced Dermatology Drug Delivery Devices Market, $Million, 2019-2030
Figure 11.15: Italy Advanced Dermatology Drug Delivery Devices Market, $Million, 2019-2030
Figure 11.16: Spain Advanced Dermatology Drug Delivery Devices Market, $Million, 2019-2030
Figure 11.17: Nordic Countries Advanced Dermatology Drug Delivery Devices Market, $Million, 2019-2030
Figure 11.18: Rest-of-Europe Advanced Dermatology Drug Delivery Devices Market, $Million, 2019-2030
Figure 11.19: Asia-Pacific Advanced Dermatology Drug Delivery Devices Market Incremental Opportunity (by Country), $Million, 2020-2030
Figure 11.20: Asia-Pacific Advanced Dermatology Drug Delivery Devices Market, $Million, 2019-2030
Figure 11.21: Asia-Pacific Advanced Dermatology Drug Delivery Devices Market (by Product Type), $Million, 2019-2030
Figure 11.22: Asia-Pacific Advanced Dermatology Drug Delivery Devices Market (by End User), $Million, 2019-2030
Figure 11.23: Japan Advanced Dermatology Drug Delivery Devices Market, $Million, 2019-2030
Figure 11.24: China Advanced Dermatology Drug Delivery Devices Market, $Million, 2019- 2030
Figure 11.25: South Korea Advanced Dermatology Drug Delivery Devices Market, $Million, 2019-2030
Figure 11.26: Australia and New Zealand Advanced Dermatology Drug Delivery Devices Market, $Million, 2019-2030
Figure 11.27: India Advanced Dermatology Drug Delivery Devices Market, $Million, 2019-2030
Figure 11.28: Rest-of-Asia-Pacific Advanced Dermatology Drug Delivery Devices Market, $Million, 2019-2030
Figure 11.29: Latin America Advanced Dermatology Drug Delivery Devices Market Incremental Opportunity (by Country), $Million, 2020-2030
Figure 11.30: Latin America Advanced Dermatology Drug Delivery Devices Market, $Million, 2019-2030
Figure 11.31: Latin America Advanced Dermatology Drug Delivery Devices Market (by Product Type), $Million, 2019-2030
Figure 11.32: Latin America Advanced Dermatology Drug Delivery Devices Market (by End User), $Million, 2019-2030
Figure 11.33: Brazil Advanced Dermatology Drug Delivery Devices Market, $Million, 2019-2030
Figure 11.34: Mexico Advanced Dermatology Drug Delivery Devices Market, $Million, 2019-2030
Figure 11.35: Argentina Advanced Dermatology Drug Delivery Devices Market, $Million, 2019-2030
Figure 11.36: Rest-of-Latin America Advanced Dermatology Drug Delivery Devices Market, $Million, 2019-2030
Figure 11.37: Rest-of-the-World Advanced Dermatology Drug Delivery Devices Market, $Million, 2019-2030
Figure 11.38: Rest-of-the-World Advanced Dermatology Drug Delivery Devices Market (by Product Type), $Million, 2019-2030
Figure 11.39: Rest-of-the-World Advanced Dermatology Drug Delivery Devices Market (by End User), $Million, 2019-2030
Figure 12.1: AptarGroup, Inc.: Overall Product Portfolio
Figure 12.2: AptarGroup, Inc. Volume Analysis (by Airless Dispensers and Bottles), Million Units, 2020
Figure 12.3: AptarGroup, Inc.: Overall Financials, 2018-2020
Figure 12.4: AptarGroup, Inc.: Net Revenue (by Segment), $Million, 2018-2020
Figure 12.5: AptarGroup, Inc.: Net Revenue (by Region), $Million, 2018-2020
Figure 12.6: AptarGroup, Inc.: R&D Expenditure, 2018-2020
Figure 12.7: AptarGroup, Inc.: SWOT Analysis
Figure 12.8: Becton, Dickinson and Company: Overall Product Portfolio
Figure 12.9: Becton, Dickinson and Company: Overall Financials, 2018-2020
Figure 12.10: Becton, Dickinson and Company: Net Revenue (by Segment), $Million, 2018-2020
Figure 12.11: Becton, Dickinson and Company: Net Revenue (by Region), $Million, 2018-2020
Figure 12.12: Becton, Dickinson and Company: R&D Expenditure, 2018-2020
Figure 12.13: Becton, Dickinson and Company: SWOT Analysis
Figure 12.14: Bespak: Overall Product Portfolio
Figure 12.15: Bespak: SWOT Analysis
Figure 12.16: Credence MedSystems, Inc.: Overall Product Portfolio
Figure 12.17: Credence MedSystems, Inc.: SWOT Analysis
Figure 12.18: E3D Elcam Drug Delivery Devices: Overall Product Portfolio
Figure 12.19: E3D Elcam Drug Delivery Devices: SWOT Analysis
Figure 12.20: Kindeva Drug Delivery L.P.: Overall Product Portfolio
Figure 12.21: Kindeva Drug Delivery L.P.: SWOT Analysis
Figure 12.22: Latch Medical: Overall Product Portfolio
Figure 12.23: Latch Medical: SWOT Analysis
Figure 12.24: LTS Lohmann Therapie-Systeme AG: Overall Product Portfolio
Figure 12.25: LTS Lohmann Therapie-Systeme AG: SWOT Analysis
Figure 12.26: Medicsensors S.L: Overall Product Portfolio
Figure 12.27: Medicsensors S.L: SWOT Analysis
Figure 12.28: Midas Pharma GmbH: Overall Product Portfolio
Figure 12.29: Midas Pharma GmbH: SWOT Analysis
Figure 12.30: Nemera: Overall Product Portfolio
Figure 12.31: Nemera: SWOT Analysis
Figure 12.32: Owen Mumford: Overall Product Portfolio
Figure 12.33: Owen Mumford: SWOT Analysis
Figure 12.34: Portal Instruments, Inc.: Overall Product Portfolio
Figure 12.35: Portal Instruments, Inc.: SWOT Analysis
Figure 12.36: Vaxxas Inc.: Overall Product Portfolio
Figure 12.37: Vaxxas Inc.: SWOT Analysis
Figure 12.38: West Pharmaceutical Services, Inc.: Overall Product Portfolio
Figure 12.39: West Pharmaceutical Services, Inc.: Overall Financials, 2018-2020
Figure 12.40: West Pharmaceutical Services, Inc.: Net Revenue (by Segment), $Million, 2018-2020
Figure 12.41: West Pharmaceutical Services, Inc.: Net Revenue (by Region), $Million, 2018-2020
Figure 12.42: West Pharmaceutical Services, Inc.: R&D Expenditure, 2018-2020
Figure 12.43: West Pharmaceutical Services, Inc.: SWOT Analysis
Market Report Coverage
|
Advanced Dermatology Drug Delivery Devices |
|||
|
Base Year |
2019 |
Market Size in 2021 |
$3,569.8 Million |
|
Forecast Period |
2021-2030 |
Value Projection and Estimation by 2030 |
$8,783.0 Million |
|
CAGR During Forecast Period |
10.52% |
Number of Tables |
34 |
|
Number of Pages |
266 |
Number of Figures |
166 |
|
Market Segmentation |
• Product Type – Hardware (Injectors (Disposable, Reusable, Wearable), Patches (Needle-less Patches, Microneedle Patches Solid Removable Microneedles, Coated Microneedles, Dissolving Microneedles, Hollow Microneedles, Hydrogel-Forming Microneedles), Airless Dispensers and Bottles, Dermal Pumps, Valves, Other Devices, Packaging Products), and Software and Apps • Sales Channel – B2B sales channel, B2C sales channel • End User – Hospitals, Dermatology Practices, Home Use |
||
|
Regional Segmentation |
• North America - U.S. and Canada • Europe - Germany, U.K., France, Italy, Spain, Nordic Countries, and Rest-of-Europe • Asia-Pacific - Japan, China, South Korea, Australia and New Zealand, India, and Rest-of-Asia-Pacific • Latin America - Brazil, Mexico, Argentina, and Rest-of-Latin America • Rest-of-the-World |
||
|
Market Growth Drivers |
• Global Preference for Connected Devices • Increasing Number of Business Synergies with Pharmaceutical Companies • Novel Technologies in Drug Delivery • Growing Focus on Prescription Adherence |
||
|
Market Challenges |
• Stringent Regulations and Concerns Around Data Privacy • Lack of Awareness of Advanced Dermatology Drug Delivery Devices Among a Large Section of the Population in Emerging Countries |
||
|
Market Opportunities |
• Development of a Customized Apps Marketplace for Pharma Companies • Leveraging Synergies to Expand into Emerging Markets • Developing Low-Cost Devices to Improve Sales in Price-Sensitive Markets |
||
|
Key Companies Profiled |
AptarGroup, Inc., Becton, Dickinson and Company, Bespak, Credence MedSystems, Inc., E3D Elcam Drug Delivery Devices, Kindeva Drug Delivery L.P., Latch Medical, LTS Lohmann Therapie-Systeme AG, Medicsensors S.L, Midas Pharma GmbH, Nemera, Owen Mumford, Portal Instruments, Inc., Vaxxas Inc., West Pharmaceutical Services, Inc. |
||
How This Report Can Add Value
Assuming that the reader is a manufacturer of dermal drug delivery devices, they will be able to do the following-
• Understand their position as compared to some of the key players in the market
• Get information on the number of units sold for each product type
• Stay updated with the latest trends in the market with respect to connected devices.
• Understand the impact of COVID-19 on dermatology practices, adoption of connected devices, and the entry barriers as a result.
• Identify some of the key players in the market and understand their value contribution
Assuming that the reader is a pharmaceutical company, they will be able to do the following-
• Understand the trends in dermatology drug delivery devices
• Stay updated with the key developments including partnerships between device manufacturers and pharmaceutical companies
• Understand the sales trend for OTC and pharma end markets
Key Questions Answered in the Global Advanced Dermatology Drug Delivery Devices Market Report
• What is the volume sold for each of the key product types in the market?
• What are some of the features of the products available in the market or in the pipeline?
• What are the key regulations governing the global advanced dermatology drug delivery devices market?
• What are the key technological developments expected to have a strong impact on the market in the coming years?
• How has the COVID-19 pandemic impacted the growth of the global advanced dermatology drug delivery devices market?
• Who are the leading players who held major share of the advanced dermatology drug delivery devices market in 2020?
• How has the patent filing trend in the field of advanced dermatology drug delivery devices grown over the years?
• What are the key factors that are expected to promote or restrain market growth?
• What are the likely scenarios in which the global advanced dermatology drug delivery devices market can grow in the future?
• What are the potential scenarios and effects of COVID-19 recovery for the advanced dermatology drug delivery devices market?
• What is the most common sales channel, and how likely is it to dominate the market during the forecast period 2021-2030?
• What is the current revenue contribution of different product types, and how is it expected to be modified during the forecast period?
• What is the current revenue contribution of different end users, and how is it expected to be modified during the forecast period?
Report Summary
Advanced Dermatology Drug Delivery Devices Market Industry Overview
The use of drug delivery devices to administer drugs through the skin is not a new concept and has been done using needle-and-syringe combinations for decades. Advanced dermatology drug delivery devices are based on the concept of drug delivery with added features for reduced pain, enhanced medication adherence, consumer engagement, user-friendly design, and ease of administration. These devices include injectors, patches, airless dispensers and bottles, dermal pumps, valves, and add-on devices for safety and enhanced connectivity.
The market currently is dominated by needle-and-syringe combination products, which is almost universally disliked, accounts for a large chunk of the market. Most of the advanced drug delivery devices aim to capture some of that share with at least one of the features mentioned previously. The primary driving factors that are expected to boost the growth of the market include the push for connected devices, increasing number of business synergies among drug delivery device manufacturers and pharmaceutical companies leading to launch of new combination products in the market, the growing focus on prescription/medication/patient adherence, and innovative technologies in drug delivery such as microneedle patches. The key effort to bridge the gap in demand for connected devices is to increase the awareness for such products in emerging countries.
The global advanced dermatology drug delivery devices market report highlights that the market was valued at $3,348.9 million in 2020 and is expected to reach $8,783.0 million by the end of 2030. The market is expected to grow at a CAGR of 10.52% during the forecast period from 2021 to 2030.
Global Advanced Dermatology Drug Delivery Devices Market Drivers
Presently, the factors driving the growth of the market as per the global advanced dermatology drug delivery devices market report include the global push for connected devices, increasing number of business synergies with pharmaceutical companies, novel technologies in drug delivery, and growing focus on prescription adherence.
As technology continues to evolve, sensors and connectivity are becoming essential elements in drug delivery. Connected devices are expected to be increasingly used for customized disease management. The market acceptance for connected devices is growing, mainly fueled by the overall increase in the adoption of connected devices and patient monitoring amidst the COVID-19 pandemic. Going forward, drug delivery devices are expected to comprise features that promote adherence. With evolving technologies, key players in the market are expected to integrate their offerings with connectivity features through apps. The growing focus on patient convenience is increasingly driving these technological advancements in the case of drug delivery.
Global Advanced Dermatology Drug Delivery Devices Market Challenges
The challenges that are restricting the growth of the market include stringent regulations and concerns around data privacy, and the lack of awareness of advanced dermatology drug delivery devices among a large section of the population in emerging countries.
The concept of connected healthcare is revolutionary. However, it also adds to data privacy concerns. Similar to all connected devices, networked medical devices are prone to security breaches. In terms of product launches, the market has registered a high rate of innovation during 2015-2020. In addition, the concept of connected medical devices is a relatively new concept and needs more time to gain acceptance among the masses, especially in emerging countries.
Global Advanced Dermatology Drug Delivery Devices Market Opportunities
Potential opportunities that are likely to boost the growth of the market include developing of a customized apps marketplace for pharma companies, leveraging synergies to expand into emerging markets, and developing low-cost devices to improve sales in price-sensitive markets.
A number of synergies between the manufacturers of advanced dermatology drug delivery devices and third-party software developers/cloud-service providers are expected to act as a catalyst for the development of the customized apps marketplace. Emerging markets present lucrative opportunities for the growth in the adoption of advanced dermatology drug delivery devices. In addition, manufacturers of advanced dermatology drug delivery devices are expected to benefit by marketing similar low-cost devices specifically for low- and middle-income countries (LMICs) to maximize their profits.
Impact of COVID-19 on the Advanced Dermatology Drug Delivery Devices Industry
The impact of COVID-19 varies depending on the region, country, the extent of lockdowns, and the perception of the local population.
In most cases, once the lockdowns were lifted, medication delivery systems in professional healthcare settings were redesigned with an aim to minimize contact among the healthcare providers and the patients. The regulations also required the clinicians to wear personal protective equipment. The adoption of advanced dermatology drug delivery devices is expected to be accelerated post COVID-19 due to the accelerated demand for connected devices. The trend of digitalizing healthcare has also impacted the development of some of the devices.
Key areas of the supply chain were impacted during the initial days of the pandemic, which comprised coinciding lockdowns in several countries leading to a restriction in global logistics. The resulting strain led to reduced stock in warehouses and a hike in logistics costs locally.
Market Segmentation
Global Advanced Dermatology Drug Delivery Devices Market (by Product Type)
The global advanced dermatology drug delivery devices market report includes advanced dermatology devices for drug delivery. These products include injectors, patches, airless dispensers and bottles, dermal pumps, valves, other devices, and software and apps.
The product segment is being driven by a number of innovations in terms of product design and user engagement. Many players are focusing on having a patient-facing app to enhance medication adherence. As a result, software developers and solution providers are getting involved. Manufacturers can also have in-house custom software development teams for the same purpose.
Global Advanced Dermatology Drug Delivery Devices Market (by Sales Channel)
The global advanced dermatology drug delivery devices market sales channel includes B2B sales channel and B2C sales channel.
Manufacturers across the globe have been focusing on expanding their network of operations either through business synergies or technological advancements in the healthcare industry. Furthermore, the drug-device combinations are usually sold only through the B2B channel.
Global Advanced Dermatology Drug Delivery Devices Market (by End User)
The global advanced dermatology drug delivery devices market by end user includes hospitals, dermatology practices, and home use.
Hospitals are the primary end users for the global advanced dermatology delivery devices market. The adoption of these devices in hospitals and dermatology practices (clinics) has been increasing continuously for vaccination purposes. Moreover, the COVID-19 pandemic has played a key role in accelerating the demand for connected and home use devices. The advancements in drug delivery devices promoting adherence are also propelling the growth of the segment.
Global Advanced Dermatology Drug Delivery Devices Market (by Region)
The different regions covered under the global advanced dermatology drug delivery devices market include North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World.
North America and Europe are two of the largest markets for advanced dermatology drug delivery devices, while developing countries are expected to register strong growth in the adoption of advanced dermatology drug delivery devices in the near future.
Key Market Players and Competition Synopsis
Some of the key players operating in the market include AptarGroup, Inc., Becton, Dickinson and Company, Bespak, Credence MedSystems, Inc., E3D Elcam Drug Delivery Devices, Kindeva Drug Delivery L.P., Latch Medical, LTS Lohmann Therapie-Systeme AG, Medicsensors S.L, Midas Pharma GmbH, Nemera, Owen Mumford, Portal Instruments, Inc., Vaxxas Inc., and West Pharmaceutical Services, Inc.
The global advanced dermatology drug delivery devices market has witnessed several strategic and technological developments in the past few years undertaken by the different market players to attain their respective market shares in this emerging domain. Some of the strategies covered in this segment are funding activities, mergers and acquisitions (M&A), partnerships, alliances, and business expansion, regulatory and legal activities, and new offerings. The preferred strategy for companies has been business synergies followed by funding activities.
Global Advanced Dermatology Drug Delivery Devices Market
Focus on Product Type, Volume Sold, Analysis and Forecast 2021-2030
Some Faq's
Frequently Asked Questions
The global advanced dermatology drug delivery devices market was valued at $3,348.9 million in 2020 and is expected to grow at a CAGR of 10.52% during the forecast period from 2021 to 2030.
The top market players are AptarGroup, Inc., Becton, Dickinson and Company, Bespak, Credence MedSystems, Inc., E3D Elcam Drug Delivery Devices, Kindeva Drug Delivery L.P., Latch Medical, LTS Lohmann Therapie-Systeme AG, Medicsensors S.L, Midas Pharma GmbH, Nemera, Owen Mumford, Portal Instruments, Inc., and Vaxxas Inc. among others.
Factors driving the growth of the market incorporate global preference for connected devices, increasing number of business synergies with pharmaceutical companies, novel technologies in drug delivery, and growing focus on prescription adherence.
The main challenges restricting the growth of the market are stringent regulations and concerns around data privacy, and lack of awareness of advanced dermatology drug delivery devices among a large section of the population in emerging countries.
The potential opportunities that are likely to boost the growth of the market include developing of a customized apps marketplace for pharma companies, leveraging synergies to expand into emerging markets, and developing low-cost devices to improve sales in price-sensitive markets.
Similar Product
You may also like